Maxidone is a medication licensed for treating moderate to moderately severe pain. This prescription medicine is a type of narcotic and is a combination of two pain relievers: hydrocodone bitartrate and acetaminophen. The product is classified as a controlled substance, meaning special laws regulate its sale and use. Potential side effects of the drug include dizziness, nausea, and vomiting.
What Is Maxidone?
Maxidone® (hydrocodone/APAP) is a prescription medication approved to treat moderate to moderately severe pain. Because Maxidone contains a narcotic, it is classified as a controlled substance, which means that special federal and state laws and regulations control its sale and use.
Hydrocodone relieves pain and coughing, but also causes drowsiness, mood changes, and mental "clouding." In the United States, hydrocodone is only available in combination with other medications; it is not available alone.
APAP is an acronym for one of the chemical names of acetaminophen, a pain reliever and fever reducer commonly found in non-prescription medications such as Tylenol®. Combining hydrocodone with acetaminophen helps improve Maxidone's effectiveness at relieving pain and may limit the abuse potential of hydrocodone, as the maximum dose of Maxidone is usually limited by the acetaminophen content.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Maxidone [package insert]. Corona, CA: Watson Pharmaceuticals, Inc.;2003 April
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 18, 2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click